Dexcom launches Time in Range campaign
Dexcom has launched a campaign to improve the understanding and accelerate the adoption of Time in Range (TIR) as the standard of care in diabetes
Dexcom has launched a campaign to improve the understanding and accelerate the adoption of Time in Range (TIR) as the standard of care in diabetes
The latest clinical trial results for the Omnipod 5 show the automated insulin delivery (AID) system can significantly increase Time in Range (TIR) and reduce
Introducing the MiniMed 670G with SmartGuard technology, the world’s first self-adjusting insulin pump system, reducing the burden of living with Type 1 diabetes. By Sue